https://store-images.s-microsoft.com/image/apps.27107.68abf223-3b10-464c-ba72-3c60b6de489c.6e32b007-1534-40e4-bdb1-8cd3d6be7f14.c65a4b71-ccfc-4d54-b378-8f85aaa12346

The DV Platform™ Accelerating Drug Development

SciMar One, Inc

The DV Platform™ Accelerating Drug Development

SciMar One, Inc

Accelerate drug development with Azure AI for R&D savings

The DV Platform™ is a Microsoft Azure-powered platform enabling pharma teams to find and operationalize clinical data to accelerate drug development. The DV Platform's™ advanced search features and pharma-specific project management tools accelerate innovation in drug development by shifting the time-consuming tasks of clinical data analytics from humans to technology. The DV Platform™ replaces outdated manual processes to dramatically reduce costs, time, and risks of moving drugs from Phase 2 to commercialization, saving lives and improving patient outcomes.


KEY BENEFITS

Advancing a drug from Phase 2 to commercialization takes 5-7 years and requires completion of >300 critical tasks by 12 cross-functional drug development teams. In one platform, the DV Platform™ orchestrates cross-functional collaboration and task completion bringing new therapies to market up to five working years faster than current manual methods. The DV Platform™:

  • Informs drug development tasks with relevant disease-specific clinical data
  • Coordinates cross-functional drug development tasks across an organization
  • Evolves stagnant business models

FIND DATA FASTER WITH ADVANCED SEARCH:

  • AI-based search tools find relevant clinical data faster than manual methods and eliminate irrelevant data from review
  • Consistently saves users 96% of analytical time and reduces data analytics costs by 50% over a 5-year development program
  • Provides full value of clinical data to extend product lifecycle
  • Accelerates task completion

OPERATIONALIZE DATA WITH PHARMA-SPECIFIC PROJECT MANAGEMENT TOOLS:

  • The DV Platform™ coordinates hundreds of tasks required to advance a drug from Phase 2 to commercialization and beyond
  • Drug development teams gain efficiencies by collaborating in one central system
  • Secure valuable IP, data, and work history in the DV Platform™. Mitigate losses due to staff turnover
50%+ COST SAVINGS:
  • The DV Platform™ typically drives cost savings of 2% - 4% of annual R&D spend

KEY FEATURES

FOR USERS:

  • Simple navigation and visualization to quickly find, share, and archive data. Easily collaborate to accelerate workflow.

By leveraging the power of Azure, the DV Platform™ helps your team become a better-informed and more-collaborative community for developing drugs that can improve patients’ lives.

  • The DV Platform™ and Machine Learning: Saves time and reduces costs by standardizing exclusions to keep irrelevant material out of the analysis process
  • The DV Platform™ and Natural Language Processing: Automates and accelerates metadata tagging to focus analysis on the disease-specific data model
  • The DV Platform™ and Azure AI: AI model learns client preferences autonomously in real-time to align relevant data to the task at hand


THE SDE + THE POWER OF AZURE = LIVES SAVED

SciMar ONE offers Better Healthcare Through Data with AI technologies that accelerate pharmaceutical drug development. The DV Platform™ was developed by scientists with deep knowledge of pharmaceutical drug development.

https://store-images.s-microsoft.com/image/apps.12312.68abf223-3b10-464c-ba72-3c60b6de489c.66f7b415-247e-4373-be12-8382fb3554cc.cefd72a4-6960-4b92-a497-7cbb9021155b
https://store-images.s-microsoft.com/image/apps.12312.68abf223-3b10-464c-ba72-3c60b6de489c.66f7b415-247e-4373-be12-8382fb3554cc.cefd72a4-6960-4b92-a497-7cbb9021155b